• 1
    Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rybo E. Triglycerides – main lipid risk factor for cardiovascular disease in women? Acta Med Scand 1985; 217: 4819.
  • 2
    Carlson LA, Böttiger LE. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm Prospective Study. Lancet 1972; 1: 8658.
  • 3
    Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study. Ann Intern Med 1979; 90: 8591.
  • 4
    Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens Suppl 1990; 8: S915.
  • 5
    Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute myocardial infarction. Am Heart J 1991; 122: 43847.
  • 6
    Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure and sex differences in myocardial infarction. Circulation 1996; 93: 4506.
  • 7
    Bengtsson C, Blohmé G, Hallberg L et al. The study of women in Gothenburg 1968–1969 – a population study. General design, purpose and sampling results. Acta Med Scand 1973; 193: 3118.
  • 8
    Bengtsson C, Hallberg L, Hällström T et al. The population study of women in Göteborg 1974–75 – the second phase of a longitudinal study. General design, purpose and sampling results. Scand J Soc Med 1978; 6: 4954.
  • 9
    Bengtsson C, Gredmark T, Hallberg L et al. The population study of women in Gothenburg 1980–81 – the third phase of a longitudinal study. Comparison between participants and non-participants. Scand J Soc Med 1989; 17: 1415.
  • 10
    Bengtsson C, Ahlqwist M, Andersson K, Björkelund C, Lissner L, Söderström M. The prospective population study of women in Gothenburg, Sweden, 1968–69 to 1992–93. Scand J Prim Health Care, 1997; 15: 2149.
  • 11
    Levine JB, Zak B. Automated determination of serum total cholesterol. Clin Chim Acta 1964; 10: 3814.
  • 12
    Lofland HB. A semiautomated procedure for the determination of triglycerides in serum. Anal Biochem 1964; 9: 393400.
  • 13
    Bengtsson C, Björkelund C, Lapidus L, Lissner L. Associations of lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. BMJ 1993; 307: 13858.
  • 14
    Sigurdsson JA, Bengtsson C. Symptoms and signs in relation to blood pressure and antihypertensive treatment. Acta Med Scand 1983; 213: 18390.
  • 15
    Lissner L, Bengtsson C, Björkelund C, Wedel H. Physical activity levels and changes in relation to longevity. A prospective study of Swedish women. Am J Epidemiol 1996; 143: 5462.
  • 16
    Bengtsson C, Hällström T, Tibblin G. Social factors, stress experience and personality traits in women with ischaemic heart disease, compared to a population sample of women. Acta Med Scand 1973; Suppl 549: 8292.
  • 17
    Cabrera C, Helgesson Ö, Wedel H, Björkelund C, Bengtsson C, Lissner L. Socioeconomic status and mortality in Swedish women: opposing trends for cardiovascular disease and cancer. Epidemiology 2001; 12: 5326.DOI: 10.1097/00001648-200109000-00012
  • 18
    Rödström K, Bengtsson C, Lissner L, Björkelund C. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. BMJ 1999; 319: 8903.
  • 19
    Carlson LA, Böttiger LE. Risk factors for ischemic heart disease in men and women. Acta Med Scand 1985; 218: 20711.
  • 20
    Kannel WB, Castelli WP. The Framingham Study of coronary disease in women. Med Tms (NY) 1972; 100: 17395.
  • 21
    Simons L. Triglyceride levels and the risk of coronary artery disease: a view from Australia. Am J Cardiol 1992; 70 (Suppl.):14H18H.
  • 22
    Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992; 70: 3H9H.
  • 23
    Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA, 1988; 260: 191721.
  • 24
    Superko HR. Small, dense, low-density lipoproteins and atherosclerosis. Curr Ather Rep 2000; 2: 22631.
  • 25
    Mulcahy R, Hickey N, Maurer B. Coronary heart disease in women. Study of the risk factors in 100 patients less than 60 years of age. Circulation 1967; 36: 57786.
  • 26
    Manolio TA, Pearson TA, Wenger NK, Barret-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol 1992; 2: 16176.
  • 27
    Arnold AZ, Moodie DS. Coronary artery disease in young women: risk factor analysis and long-term follow up. Cleve Clin J Med 1993; 60: 3938.
  • 28
    Verschuren WMM, Kromhout D. Total cholesterol concentration and mortality at a relatively young age: do men and women differ? BMJ 1995; 311: 77983.
  • 29
    Assman G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998; 19 (Suppl. A): A2A11.
  • 30
    Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 2139.
  • 31
    Iso H, Naito Y, Sato S et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 2001; 153: 4909.